Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

NCT06184750 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

NIH

Sponsor class

Conditions

Breast Atypical Ductal Hyperplasia
Breast Atypical Lobular Hyperplasia
Breast Carcinoma
Breast Ductal Carcinoma In Situ
Breast Lobular Carcinoma In Situ
Estrogen Receptor-Positive Breast Carcinoma

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Mammography
OTHER: Questionnaire Administration
DRUG: Tamoxifen

Sponsor

National Cancer Institute (NCI)